The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro

Metabolism: Clinical and Experimental
R C O'Brien, M Luo

Abstract

Diabetes is associated with increased oxidant stress. This may contribute to the development of diabetic macrovascular complications through increased oxidation of low-density lipoprotein (LDL), which is thought to be a crucial step in the development of atherosclerosis. The sulfonylurea gliclazide has been shown to have free radical-scavenging activity in vitro, but its effects on LDL oxidation, and these effects of other sulfonylureas, are unknown. To investigate this we studied the effects of in vitro supplementation with gliclazide 1 mumol/L on copper-induced oxidation of LDL isolated from 20 control subjects and 22 type II diabetic patients. The effects of 1 mumol/L vitamin C, a known water-soluble antioxidant, were studied simultaneously. The resistance to oxidation, expressed as the lag time between the addition of copper and commencement of oxidation, was significantly increased by both gliclazide and vitamin C, and the effect was similar for LDL from diabetic and control subjects. The baseline oxidation lag time was 63.4 +/- 2.1 minutes, and increased to 108 +/- 4.4 minutes with gliclazide and 88.7 +/- 5.6 minutes with vitamin C (P = .0001, baseline v either treatment). The increase in lag time with gliclazide of 70% +...Continue Reading

Citations

Sep 11, 2016·Naunyn-Schmiedeberg's Archives of Pharmacology·Amal M MahfozAfaf A Shoka
Jun 28, 2001·Journal of Atherosclerosis and Thrombosis·H NomuraA Iguchi
Sep 5, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·D FavaG De Mattia
Jan 31, 2006·Diabetes Care·Mike J SampsonDavid A Hughes
Oct 18, 2000·Biochemical and Biophysical Research Communications·N OhgamiH Nakayama
Sep 27, 2000·Journal of Diabetes and Its Complications·S VallejoL Rodríguez-Mañas
Sep 27, 2000·Journal of Diabetes and Its Complications·S VallejoL Rodríguez-Mañas
Jul 10, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·W Grady SmithFred H Faas
May 23, 2006·Metabolism: Clinical and Experimental·Jean-Claude MamputuGeneviève Renier
Apr 25, 2006·Metabolism: Clinical and Experimental·Antonio Ceriello
Feb 29, 2000·Metabolism: Clinical and Experimental·G RenierO Serri

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

© 2021 Meta ULC. All rights reserved